samedan logo
home > pmps > winter 2020 > counteracting the effects of an opioid overdose
Pharmaceutical Manufacturing and Packing Sourcer

Counteracting the Effects of an Opioid Overdose

Respiratory depression can occur from accidental and/or intentional overdose of opioid type substances. The neurochemical process, by which the opioid substance binds with opioid receptors in the brain stem and then desensitises the level of carbon dioxide in the blood stream, fails to activate the breathing mechanisms, leading to respiratory failure and death (1). The overdose process can be interrupted and reversed with the administration of an opioid antagonist, such as naloxone, thereby blocking the effects of the ingested opioids.

In 1971, the FDA approved naloxone, the opioid antagonist, reversal medication for public use. This life-saving medication was initially labeled for intravenous, intramuscular, or subcutaneous use. For nearly 50 years, naloxone has been used by emergency medical personnel to counteract the effects of opioid overdoses (1). According to the Centers for Disease Control and Prevention, the administration of naloxone from the years 1996 to 2014 assisted in reversing the effects of opioid overdoses in an estimated 26,000 opioid users (2).

Read full article from PDF >>

Rate this article You must be a member of the site to make a vote.  
Average rating:

There are no comments in regards to this article.

 You must be a member of the site to make a comment.
About the author

Dr Todd Pizitz is a licensed clinical and forensic psychologist in private practice in Vista, California. As a forensic psychologist, Todd works with those afflicted with various types of addiction. For the past 17 years, he has worked closely with private and public defense attorneys, family court services, the District Attorney’s Office, county adult and juvenile probation, drug court, and federal probation. Todd routinely conducts psychological evaluations on those involved in the legal system.

Donald R Mealing is a Business Entrepreneur with more than 25 years’ experience as a CEO over a variety of successful businesses. Don has served on numerous Boards, including 14 years on the Board of Regents, Harris Manchester College, Oxford University, UK. He was Founder and CEO of American Corrective Counseling Services, one of the largest private counselling diversion companies servicing courts and prosecutors across the US criminal justice system. Don has lost three close relatives to opioid overdose.
Print this page
Send to a friend
Privacy statement
News and Press Releases

Nemera to build state-of-the-art manufacturing facility in Poland to serve more customers and patients

Based in Szczecin, this facility extends Nemera’s manufacturing capabilities and will bring more drug delivery device solutions to patients. Following the dynamic growth of the drug delivery devices market, as a world leader, Nemera is thrilled to extend its manufacturing capabilities in Poland.
More info >>

White Papers

Quality By Design

Biopharma Group

Quality by Design (QbD) is a systematic approach to development that begins with the defined objectives and emphasizes science and quality risk management in order to achieve those goals. QbD ensures that the quality of the product is built into production processes from the outset, rather than being tested after development has already commenced.
More info >>




©2000-2011 Samedan Ltd.
Add to favourites

Print this page

Send to a friend
Privacy statement